42
Pharmaceutical drug development services; pharmaceutical
drug development services via software using artificial
intelligence; pharmaceutical drug development services via
software using machine learning; preclinical drug discovery
and development services used for identifying, designing
and/or optimizing chemical compounds; preclinical drug
discovery and development services used for identifying,
designing and/or optimizing chemical compounds via software
using artificial intelligence; preclinical drug discovery
and development services used for identifying, designing
and/or optimizing chemical compounds via software using
machine learning; pharmaceutical evaluation and preclinical
evaluation of chemical series or lead compounds in drug
discovery; pharmaceutical evaluation and preclinical
evaluation of chemical series or lead compounds in drug
discovery via software using artificial intelligence;
pharmaceutical evaluation and preclinical evaluation of
chemical series or lead compounds in drug discovery via
software using machine learning; pharmaceutical drug
development and discovery services, namely, identifying,
designing, optimizing, and developing chemical lead series
or lead compounds via software using artificial
intelligence, machine learning, computational modeling,
DNA-encoded library screening platform, high-throughput
screening, medicinal chemistry, ADME, biology, pharmacology
and/or non-GLP safety testing
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen